APA (7th ed.) Citation

L, F., JC, C., M, R., S, N., V, C., C, A., . . . P, V. (2023). Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations. Clinical genetics, 104(5), 554. https://doi.org/10.1111/cge.14410

Chicago Style (17th ed.) Citation

L, Faivre, et al. "Low Risk of Embryonic and Other Cancers in PIK3CA-related Overgrowth Spectrum: Impact on Screening Recommendations." Clinical Genetics 104, no. 5 (2023): 554. https://doi.org/10.1111/cge.14410.

MLA (9th ed.) Citation

L, Faivre, et al. "Low Risk of Embryonic and Other Cancers in PIK3CA-related Overgrowth Spectrum: Impact on Screening Recommendations." Clinical Genetics, vol. 104, no. 5, 2023, p. 554, https://doi.org/10.1111/cge.14410.